CVS HEALTH CORP (CVS:NYSE)
$94.66 -0.63 (-0.6611%)
Analysed CVS HEALTH CORP (CVS:NYSE) News Sources
2 Large-Cap Stocks with Exciting Potential and 1 We Find Risky
08-09-2026
yahoo.com
Wall Street Loves CVS Health Stock Right Now. Should You?
09-09-2026
fool.com
Mitch Gould Brings Decades of Retail Sales Experience to ECRM
09-09-2026
yahoo.com
CVS Health marks 20 years of free community health screening program as new survey reveals many U.S. adults still face barriers to preventive health screenings
09-09-2026
yahoo.com
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
09-09-2026
yahoo.com
CVS Health Marks 20 Years of Free Community Health Screening Program As New Survey Reveals Many U.S. Adults Still Face Barriers to Preventive Health Screenings
09-09-2026
yahoo.com
CVS Still Sees 'High-Trend' Cost Growth; Oscar, UNH Stock Fall
09-09-2026
yahoo.com
CVS Health Eyes Margin Recovery, Cash Flow as 2027 Headwinds Loom
10-09-2026
marketbeat.com
Updated COVID-19 Vaccines Available at CVS Pharmacy and MinuteClinic Across the U.S.
10-09-2026
yahoo.com
Should You Buy, Hold or Sell CVS Stock Amid Consumer Wellness Growth?
10-09-2026
yahoo.com
What is the current price of CVS HEALTH CORP (CVS:NYSE)?
The current price of CVS HEALTH CORP (CVS:NYSE) is $94.66.
CVS HEALTH CORP (CVS:NYSE) absolute price change since previous trading day?
The absolute price change of CVS HEALTH CORP (CVS:NYSE) since the previous trading day is $-0.63.
CVS HEALTH CORP (CVS:NYSE) percentage price change since previous trading day?
The percentage price change of CVS HEALTH CORP (CVS:NYSE) since the previous trading day is -0.6611%.
What is the most recent average sentiment score for CVS HEALTH CORP (CVS:NYSE)?
The most recent average sentiment score for CVS HEALTH CORP (CVS:NYSE) is 38 out of 100.
What is the most recent average sentiment for CVS HEALTH CORP (CVS:NYSE)?
The most recent sentiment for CVS HEALTH CORP (CVS:NYSE) is .
SEC-8K** Filing Available For CVS HEALTH CORP (CVS:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.